Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergen molecules: tools to study effector cell activation.

R Valenta1, D Kraft

  • 1Department of Pathophysiology, Vienna General Hospital, University of Vienna, Austria. Rudolf.Valenta@akh-wien.ac.at

Immunological Reviews
|April 9, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal response to high negative affective stimuli in major depressive disorder: An fMRI study.

Journal of affective disorders·2021
Same author

E-cadherin mediated cell-biomaterial interaction reduces migration of keratinocytes in-vitro.

Colloids and surfaces. B, Biointerfaces·2019
Same author

Self-consistent gradient flow for shape optimization.

Optimization methods & software·2017
Same author

IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment.

Allergy·2015
Same author

NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells.

Leukemia·2015
Same author

Control of proliferation and osteogenic differentiation of human dental-pulp-derived stem cells by distinct surface structures.

Acta biomaterialia·2013
Same journal

Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.

Immunological reviews·2026
Same journal

Macrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.

Immunological reviews·2026
Same journal

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity.

Immunological reviews·2026
Same journal

Tissue-Resident Memory T Cells in the Heart: An Emerging Role in Chronic Inflammation.

Immunological reviews·2026
Same journal

Rethinking Immunity in Tissues: The Biology of Tertiary Lymphoid Structures.

Immunological reviews·2026
Same journal

Inflammation-Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity.

Immunological reviews·2026
See all related articles

Understanding Type I allergy involves IgE antibody activation. Reconfiguring allergen structures and IgE epitopes may lead to hypoallergenic immunogens for safer allergy immunotherapy.

Area of Science:

  • Immunology
  • Structural Biology
  • Allergy Research

Background:

  • Type I allergy is an IgE antibody-mediated hypersensitivity affecting 25% of the population.
  • Structurally defined recombinant allergens and human monoclonal IgE/IgG antibodies are now available.
  • Understanding allergen-epitope interactions is crucial for allergy research.

Purpose of the Study:

  • To review structural data on allergens and their IgE epitopes.
  • To discuss allergen recognition by IgE and IgG antibodies.
  • To explore the impact of epitope arrangement on effector cell activation.

Main Methods:

  • Analysis of three-dimensional allergen structures.
  • Review of in vitro and in vivo studies using defined allergen molecules and antibodies.

Related Experiment Videos

  • Investigation of IgE epitope density and geometrical arrangement.

    • Main Results:

    • Epitope density and arrangement significantly influence effector cell activation.
    • Structural insights support the hypothesis on epitope-mediated allergic responses.
    • Defined allergen molecules and antibodies facilitate detailed mechanistic studies.

    Conclusions:

    • Delineating structural requirements for effector cell activation is key.
    • Allergens may be engineered into hypoallergenic immunogens by reorienting IgE epitopes.
    • Allergen derivatives could enable safer, specific immunotherapy with reduced anaphylactic risk.